AI assistant
Sending…
GoodRx Holdings, Inc. — Director's Dealing 2021
Jun 14, 2021
31919_dirs_2021-06-14_677ef378-704c-426c-aad3-e1434256b641.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GoodRx Holdings, Inc. (GDRX)
CIK: 0001809519
Period of Report: 2021-06-10
Reporting Person: KOSECOFF JACQUELINE B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-10 | Class A Common Stock | A | 6138 | $0.00 | Acquired | 6138 | Direct |
Footnotes
F1: Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) the one-year anniversary of June 10, 2021 and (ii) the date of the 2022 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.
More from GoodRx Holdings, Inc.
Regulatory Filings
2026
Mar 18
Board/Management Information
2026
Feb 27
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 5